发明名称 |
Method and activated lymphocyte preparations for preventing recurrence of carcinoma |
摘要 |
Activated lymphocytes are administered to a cancer patient at least five or more times within eight months after performing surgical and chemotherapeutic treatment or radiotherapy for treating cancer particularly liver cancer, so that recurrence of the cancer can be prevented over a long period of five or more years. The activated lymphocytes to be administered while performing treatment of cancer may be autologously derived from a cancer patient or collected from the other cancer patient at need. The activated lymphocytes can be cultivated for proliferating or activating lymphocyte cells collected in the presence of solid-phase anti-CD3 antigen and interleukin 2.
|
申请公布号 |
US7105155(B2) |
申请公布日期 |
2006.09.12 |
申请号 |
US20010944360 |
申请日期 |
2001.09.04 |
申请人 |
LYMPHOTEC, INC |
发明人 |
SEKINE TERUAKI;TAKAYAMA TADATOSHI |
分类号 |
A61K35/00;C12N5/06;A61K35/12;A61K35/14;A61K35/26;A61P35/00;A61P35/04;C12N5/07;C12N5/09;G06Q50/22;G06Q50/24 |
主分类号 |
A61K35/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|